1-2 of 2
Maria Laura Dessanti
Close
Sort by
Journal Articles

FCR (Fludarabine, Cyclophosphamide, Rituximab) Followed By 90 yttrium Ibritumomab Tiuxetan for the Treatment of Relapsed Grades 1 and 2 Follicular Lymphoma. Long Term Efficacy and Safety Results of 9 Cases

Francesco Pisani, Member, ID:, 1012314, Maria Laura Dessanti, MD, Diana Giannarelli, MS, Ramy Kayal, MD, Francesco Marchesi, MD, Rosa Sciuto, MD, Sandra Rea, MD, Carlo Ludovico Maini, MD, Mirella Marino, MD
Journal: Blood
Blood (2014) 124 (21): 5452.
https://doi.org/10.1182/blood.V124.21.5452.5452
Published: 2014
Journal Articles

Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myeloma

Clinical Trials & Observations
Michele Cavo, Lucia Pantani, Maria Teresa Petrucci, Francesca Patriarca, Elena Zamagni, Daniela Donnarumma, Claudia Crippa, Mario Boccadoro, Giulia Perrone, Antonietta Falcone, Chiara Nozzoli, Renato Zambello, Luciano Masini, Anna Furlan, Annamaria Brioli, Daniele Derudas, Stelvio Ballanti, Maria Laura Dessanti, Valerio De Stefano, Angelo Michele Carella, Magda Marcatti, Andrea Nozza, Felicetto Ferrara, Vincenzo Callea, Catello Califano, Annalisa Pezzi, Anna Baraldi, Mariella Grasso, Pellegrino Musto, Antonio Palumbo
Journal: Blood
Blood (2012) 120 (1): 9–19.
https://doi.org/10.1182/blood-2012-02-408898
Published: 2012
Includes: Supplemental data